ada guidelines glp-1 2026 Diabetes Treatment Update: vs NICE 2026 ADA Standards Update: GLP-1

Sinclair, Alex Evaluation of cognitive performance with medicines for raised intracranial pressure: implications for spaceflight associated neuro-ocular syndrome [abstract]

Prior weight loss attempts (diet, exercise, or other medications) also need documentation

It may be a better fit for patients seeking more robust weight loss potential, patients with stronger appetite signals, or patients who did not get their desired response from semaglutide

This might occur when a patient initially started on orforglipron for convenience but subsequently decides that greater weight loss efficacy is needed

We just don't know them yet What amazes me is that people are surprised by this

Buijs, R